Current and future directions of immunotherapy research

Five years of letrozole does not improve disease free survival for pretreated HR positive breast cancer

Matched mutations and long term letrozole for breast cancer

No benefit for adjuvant ibandronate at 3 years in early breast cancer

UN joint program on cervical cancer prevention and control

Health, equity and womens cancers

The International Cancer Control Partnership

Women and health - the key to sustainable development

Cancer control as a global development goal

Cancer care in emergency settings

Cancer control in Africa - best practices and beyond

High cost as a threat to care